Pages that link to "Item:Q1783605"
From MaRDI portal
The following pages link to Mathematical modeling of pulmonary tuberculosis therapy: insights from a prototype model with rifampin (Q1783605):
Displaying 10 items.
- Modeling nanoparticle delivery of TB drugs to granulomas (Q304666) (← links)
- Understanding PGE2, LXA4 and LTB4 balance during \textit{Mycobacterium tuberculosis} infection through mathematical model (Q304757) (← links)
- Mathematical modeling and systems pharmacology of tuberculosis: isoniazid as a case study (Q327196) (← links)
- Mathematical model on pulmonary and multidrug-resistant tuberculosis patients with vaccination (Q458932) (← links)
- Modeling basic aspects of bacterial resistance of Mycobacterium tuberculosis to antibiotics (Q722231) (← links)
- Nonlinear growth and mathematical modelling of COVID-19 in some African countries with the Atangana-Baleanu fractional derivative (Q2060643) (← links)
- Dynamic mathematical model development and validation of \textit{in vitro Mycobacterium smegmatis} growth under nutrient- and pH-stress (Q2243110) (← links)
- A computational tool integrating host immunity with antibiotic dynamics to study tuberculosis treatment (Q2415779) (← links)
- <i>YAGYOPATHY</i> VERSUS ORAL AND IV DRUG ADMINISTRATION: EVALUATION FOR PULMONARY TUBERCULOSIS USING COMPARTMENT MODELING (Q3445566) (← links)
- A pipeline for testing drug mechanism of action and combination therapies: from microarray data to simulations via linear-in-flux-expressions. Testing four-drug combinations for tuberculosis treatment (Q6133977) (← links)
